B Kreis, L Israël, S Pretet. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AbsenteeismAdultDrug SynergismHumansIsoniazid/therapeutic useMaleMiddle AgedPrognosisRifampin/therapeutic useStreptomycin/therapeutic useTuberculosis, Pulmonary/drug therapy
Substances: See more » IsoniazidRifampinStreptomycin
Year: 1969 PMID: 5387445
Source DB: PubMed Journal: Rev Tuberc Pneumol (Paris) ISSN: 0035-1792